ATOSSA THERAPEUTICS, INC. Investment Income, Interest
ATOSSA THERAPEUTICS, INC. (ATOS) reported Investment Income, Interest of $227.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $227.00K, a 64.81% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-03-31 was $309.00K, a 57.08% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $442.00K, a 47.19% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $570.00K, a 43.06% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $2.38M, a 41.31% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $4.05M, a 6.75% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. investment income, interest for fiscal 2023 was $4.34M, a 395.21% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. investment income, interest for fiscal 2022 was $877.00K, a 14516.67% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 41 month | Investment Income, Interest 44 month | Investment Income, Interest 47 month | Investment Income, Interest 50 month | Investment Income, Interest 53 month | Investment Income, Interest 56 month | Investment Income, Interest 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $227.00K 10-Q · filed 2026-08-07 | $536.00K 10-Q · filed 2026-08-07 | $978.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.55M derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2026-03-31 | $309.00K 10-Q · filed 2026-05-08 | $751.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.32M derived: sum of 3 quarters · filed 2026-05-08 | $1.97M derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.01M derived: sum of 2 quarters · filed 2026-03-25 | $1.66M derived: sum of 3 quarters · filed 2026-08-07 | $2.38M 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | $570.00K 10-Q · filed 2025-11-12 | $1.22M derived: sum of 2 quarters · filed 2026-08-07 | $1.94M 10-Q · filed 2025-11-12 | $2.77M derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-06-30 | $645.00K 10-Q · filed 2026-08-07 | $1.36M 10-Q · filed 2026-08-07 | $2.20M derived: sum of 3 quarters · filed 2026-08-07 | $3.20M derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-03-31 | $720.00K 10-Q · filed 2026-05-08 | $1.56M derived: sum of 2 quarters · filed 2026-05-08 | $2.56M derived: sum of 3 quarters · filed 2026-05-08 | $3.63M derived: sum of 4 quarters · filed 2026-05-08 | |||||||
| 2024-12-31 | $837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.84M derived: sum of 2 quarters · filed 2026-03-25 | $2.91M derived: sum of 3 quarters · filed 2026-03-25 | $4.05M 10-K · filed 2026-03-25 | |||||||
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-12 | $2.07M derived: sum of 2 quarters · filed 2025-11-12 | $3.21M 10-Q · filed 2025-11-12 | $4.45M derived: sum of 4 quarters · filed 2025-11-12 | |||||||
| 2024-06-30 | $1.07M 10-Q · filed 2025-08-12 | $2.21M 10-Q · filed 2025-08-12 | $3.45M derived: sum of 3 quarters · filed 2025-08-12 | $4.72M derived: sum of 4 quarters · filed 2025-08-12 | |||||||
| 2024-03-31 | $1.14M 10-Q · filed 2025-05-13 | $2.37M derived: sum of 2 quarters · filed 2025-05-13 | $3.65M derived: sum of 3 quarters · filed 2025-05-13 | $4.63M derived: sum of 4 quarters · filed 2025-05-13 | |||||||
| 2023-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $2.51M derived: sum of 2 quarters · filed 2025-03-25 | $3.49M derived: sum of 3 quarters · filed 2025-03-25 | $4.34M 10-K · filed 2025-03-25 | |||||||
| 2023-09-30 | $1.27M 10-Q · filed 2024-11-12 | $2.26M derived: sum of 2 quarters · filed 2024-11-12 | $3.11M 10-Q · filed 2024-11-12 | $3.78M derived: sum of 4 quarters · filed 2024-11-12 | |||||||
| 2023-06-30 | $983.00K 10-Q · filed 2024-08-12 | $1.83M 10-Q · filed 2024-08-12 | $2.50M derived: sum of 3 quarters · filed 2024-08-12 | $2.70M derived: sum of 4 quarters · filed 2024-08-12 | |||||||
| 2023-03-31 | $850.00K 10-Q · filed 2024-05-13 | $1.52M derived: sum of 2 quarters · filed 2024-05-13 | $1.71M derived: sum of 3 quarters · filed 2024-05-13 | $1.73M derived: sum of 4 quarters · filed 2024-05-13 | |||||||
| 2022-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $864.00K derived: sum of 2 quarters · filed 2024-04-01 | $875.00K derived: sum of 3 quarters · filed 2024-04-01 | $877.00K 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | $194.00K 10-Q · filed 2023-11-13 | $205.00K derived: sum of 2 quarters · filed 2023-11-13 | $207.00K 10-Q · filed 2023-11-13 | ||||||||
| 2022-06-30 | $11.00K 10-Q · filed 2023-08-14 | $13.00K 10-Q · filed 2023-08-14 | |||||||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 | ||||||||||
| 2021-12-31 | $6.00K 10-K · filed 2023-03-22 | ||||||||||
| 2015-03-31 | $279.00 10-Q · filed 2015-05-13 | $385.00 derived: sum of 2 quarters · filed 2015-05-13 | $396.00 derived: sum of 3 quarters · filed 2015-05-13 | $396.00 derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-12-31 | $106.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $117.00 derived: sum of 2 quarters · filed 2015-03-30 | $117.00 derived: sum of 3 quarters · filed 2015-03-30 | $260.00 10-K · filed 2015-03-30 | |||||||
| 2014-09-30 | $11.00 10-Q · filed 2014-11-12 | $11.00 derived: sum of 2 quarters · filed 2014-11-12 | $154.00 10-Q · filed 2014-11-12 | $396.00 derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $143.00 10-Q · filed 2014-08-12 | $385.00 derived: sum of 3 quarters · filed 2015-05-13 | $438.00 derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-03-31 | $143.00 10-Q · filed 2015-05-13 | $385.00 derived: sum of 2 quarters · filed 2015-05-13 | $438.00 derived: sum of 3 quarters · filed 2015-05-13 | $438.00 derived: sum of 4 quarters · filed 2015-05-13 | $7.03K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $242.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $295.00 derived: sum of 2 quarters · filed 2015-03-30 | $295.00 derived: sum of 3 quarters · filed 2015-03-30 | $295.00 10-K · filed 2015-03-30 | $6.88K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $53.00 10-Q · filed 2014-11-12 | $53.00 derived: sum of 2 quarters · filed 2014-11-12 | $53.00 10-Q · filed 2014-11-12 | $53.00 derived: sum of 4 quarters · filed 2014-11-12 | $6.64K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | $0.00 derived: sum of 3 quarters · filed 2014-08-12 | $46.00 derived: sum of 4 quarters · filed 2014-08-12 | $6.59K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $46.00 derived: sum of 3 quarters · filed 2014-05-14 | $356.00 derived: sum of 4 quarters · filed 2014-05-14 | $6.59K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $46.00 derived: sum of 2 quarters · filed 2014-03-27 | $356.00 derived: sum of 3 quarters · filed 2014-03-27 | $1.22K 10-K · filed 2014-03-27 | $6.59K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $46.00 10-Q · filed 2013-11-12 | $356.00 derived: sum of 2 quarters · filed 2013-11-12 | $1.22K 10-Q · filed 2013-11-12 | $2.71K derived: sum of 4 quarters · filed 2013-11-12 | $6.59K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $310.00 10-Q · filed 2013-08-14 | $1.17K 10-Q · filed 2013-08-14 | $2.66K derived: sum of 3 quarters · filed 2013-08-14 | $4.93K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | $863.00 10-Q · filed 2013-05-15 | $2.35K derived: sum of 2 quarters · filed 2013-05-15 | $4.62K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||
| 2011-12-31 | $1.49K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $3.75K derived: sum of 2 quarters · filed 2013-03-28 | $4.91K 10-K · filed 2013-03-28 | ||||||||
| 2011-09-30 | $2.27K 10-Q/A · filed 2013-01-22 | $3.43K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |